Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Nov-Dec;20(10):1939-45.

Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images

Affiliations

Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images

A Rovira et al. AJNR Am J Neuroradiol. 1999 Nov-Dec.

Abstract

Background and purpose: Magnetization-transfer imaging is a technique that could provide indirect evidence of the characteristics of multiple sclerosis (MS) lesions. The purpose of this work was to study the evolution of MS lesions on T1-weighted MR images over time and to investigate changes in magnetization-transfer ratio (MTR) values of MS lesions with different initial appearances on contrast-enhanced T1-weighted images.

Methods: Eleven patients with relapsing-remitting MS were studied with MR imaging. The MTRs were calculated for 47 lesions that had been classified according to their appearance on contrast-enhanced T1-weighted images. Each patient was examined at four time points over a 1-year period. The MTR changes observed in the selected lesions were compared with their initial T1-weighted appearance.

Results: The lowest MTR values were initially found in hypointense nonenhancing lesions and in ring-enhancing lesions, with both types showing a hypointense center. Changes in MTR values were more dynamic and reversible in ring-enhancing than in hypointense nonenhancing plaques. Nodular-enhancing lesions had slightly lower initial MTRs than did isointense non-enhancing lesions.

Conclusion: The absence or presence of contrast uptake may indicate a different pathologic basis for hypointense MS lesions on T1-weighted MR images. These differences should be kept in mind when considering T1 lesion load as a surrogate marker of disability in MS.

PubMed Disclaimer

Figures

<sc>fig</sc> 1.
fig 1.
Two-dimensional plot of mean MTR values versus time (in months). MTR values are stratified according to the appearance of MS lesions on the baseline contrast-enhanced T1-weighted image. Hypointense nonenhancing, nodular-enhancing, and ring-enhancing lesions show a significant MTR increase on the 12-month image. The increase is higher for ring-enhancing lesions and occurs mainly during the first 3 months. MTR values in the NAWM and the isointense nonenhancing lesions do not show significant changes. Open circles indicate NAWM; triangles, isointense without enhancement; solid circles, nodular-type enhancement; squares, hypointense without enhancement; diamonds, ring-type enhancement.
<sc>fig</sc> 2.
fig 2.
A–C, T1 isointense nonenhancing lesion in the right frontal white matter. Axial T2-weighted image (2200/80/1) (A) and contrast-enhanced T1-weighted image (550/14/2) (B) at a comparable anatomic level are shown at day 0 and at 12 months (C). The lesion (arrow, A) shows no significant change on the 12-month image, and the MTR values remained between 35% on the baseline image and 33% on the 12-month image.
<sc>fig</sc> 3.
fig 3.
A–C, Serial MR follow-up of a ring-enhancing lesion in the left periventricular temporal white matter. The lesion (arrow, A) is shown at three time points: baseline (A), 1 month (B), and 12 months (C) on contrast-enhanced T1-weighted images (550/14/2). The ring-enhancing pattern at baseline disappears on the 1-month image. At 12 months, the lesion is completely isointense with respect to NAWM on contrast-enhanced T1-weighted images. In this lesion, the MTR increased from 22% on the baseline image to 36% after 12 months.
<sc>fig</sc> 4.
fig 4.
A and B, Serial MR follow-up of a nodular-enhancing lesion in the right frontal white matter and a nonenhancing hypointense lesion (arrow, A) in the left frontal white matter (arrowhead, A) on contrast-enhanced T1-weighted images (550/14) at baseline (A) and 12 months later (B). The nodular-enhancing lesion has become completely isointense on the 12-month image. In this lesion, the MTR increased from 34% on the baseline image to 39% on the 12-month image. The nonenhancing lesion in the left frontal lobe shows no significant change on the serial MR follow-up images, and the MTR values remained between 24% on the baseline image and 26% on the 12-month image.

Similar articles

Cited by

References

    1. Whitaker JN, McFarland HF, Rudge P, Reingold SC, Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis 1995;1:37-47 - PubMed
    1. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16 - PubMed
    1. Miller DH, Grossman RI, Reingold SC, McFarland HF, The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24 - PubMed
    1. Runge VM, Price AC, Kirshner HS, et al. MR imaging of MS: a study of pulse-techniques efficiency. AJR Am J Roentgenol 1984;143:1015-1026 - PubMed
    1. Ormerod IEC, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579-1616 - PubMed

Publication types